Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzymaster develops proprietary enzymes and biocatalytic processes to enable greener and more efficient production of pharmaceutical intermediates and fine chemicals. Their platforms are used by pharma/chemical companies to improve synthesis routes but they do not report clinical results as they are not a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzymaster (Ningbo) Bio-Engineering Co., Ltd..